钱塘老娘舅

Kajol Celebrates 24 Years of Kabhi Khushi Kabhie Gham With Fun Post_我的网站

一 |     Kajol marked the 24th anniversary of Kabhi Khushi Kabhie Gham with a heartfelt and playful post on social media. Sharing two memorable pictures from the film, the actor celebrated the journey of Anjali, a character that remains one of the most beloved roles of her career.     One picture showed a goofy moment featuring Anjali, capturing her loud, carefree personality that audiences instantly connected with. The second image was a warm group hug from a key scene in the film, featuring the entire main cast together, Shah Rukh Khan, Kareena Kapoor Khan, Amitabh Bachchan, Jaya Bachchan, Hrithik Roshan and Kajol. The picture perfectly reflected the emotional core of the film, which revolved around love, family and togetherness.     Along with the images, Kajol wrote, “To all the Anjali’s out there, keep being loud and proud! Rahul is out there somewhere but he might be late because of traffic.” The caption instantly struck a chord with fans, reminding them of Anjali and Rahul’s iconic love story.     Check out her post here:                                                                      View this post on Instagram          A post shared by Kajol Devgan (@kajol)                    Released in 2001 and directed by Karan Johar, Kabhi Khushi Kabhie Gham went on to become a cultural phenomenon. Its emotional storytelling, memorable dialogues, grand music and powerful performances helped it achieve cult status over the years. Even after 24 years, the film continues to be celebrated across generations.     Kajol’s character Anjali, with her bold personality and emotional depth, remains one of the most relatable female characters in Hindi cinema. Fans flooded the comments section with love, Anjali's GIF, sharing their favourite scenes and dialogues from the film.     On the work front, Kajol is currently enjoying a successful run as a talk show host. She co-hosts the show Too Much with Kajol and Twinkle alongside Twinkle Khanna. The show has been receiving positive response for its candid conversations, humour and honest takes on life, relationships and the film industry. As K3G completes 24 years, Kajol’s post is a reminder of why the film continues to live on in pop culture.     Also Read: Shah Rukh Khan and Kajol’s Best Moments From 2025。    CVS Health is planning to remove one type of a common decongestant from shelves after an advisory committee to the U.S. Food and Drug Administration said it was ineffective earlier this year.The products contain the oral formulation of phenylephrine (PE), which is found in several over-the-counter (OTC) medications.Although PE has been used as a decongestant for nearly a century, experts have been questioning its efficacy for years.The FDA Nonprescription Drugs Advisory Committee unanimously voted in September that PE did not improve nasal congestion any more than a placebo at the dosage given for OTC use.In response, CVS said it is removing products, in which PE is the only active ingredient from store shelves. This means products like Dayquil, which used a combination of active ingredients, will remain available for purchase."We are aware of the FDA Advisory Committee's position on oral phenylephrine (PE) and will follow direction from the FDA to ensure products we sell comply with all laws and regulations," CVS Health said in a statement. "We are removing certain oral cough and cold products that contain phenylephrine as the only active ingredient from CVS Pharmacy stores. Other oral cough and cold products will continue to be offered to meet consumer needs."CVS did not give specifies on brands that will be removed.The FDA told ABC News it has not yet determined whether it no longer considers PE to be a safe and effective medication and has not ordered the product to be removed from shelves. CVS's move is voluntary."The FDA has no further information to provide at this time regarding the timing of any decision the agency may make following the advisory committee meeting," the federal health agency said.The Consumer Healthcare Products Association told ABC News that the advisory committee's recommendation is a non-binding decision and not a change in regulation."FDA is currently in the process of reviewing the regulatory status of oral phenylephrine (PE) following September's advisory committee meeting," CHPA said in a statement. "Until FDA makes a determination on the committee's recommendation, oral PE remains a Category 1 OTC ingredient, which is generally recognized as safe and effective."Concerns were first raised about PE in 2007. Since then, evidence has accumulated showing that the drug offers little to no relief for nasal congestion.Experts believe this is because the body processes the drug before it reaches the nasal passages where it needs to work.It's unclear if other major retail pharmacy chains will follow in CVS's footsteps.Walgreens Boots Alliance would not disclose whether it was planning to remove products with PE from store shelves and said it would defer to the FDA."Walgreens follows FDA regulations. We are closely monitoring the situation and actively partnering with the Walgreens Office of Clinical Integrity and suppliers on appropriate next steps," a Walgreens spokesperson told ABC News.Other major pharmacy chains including Albertsons, Costco and Kroger did immediately reply to ABC News' request for comment. Walmart did not have an answer immediately available.ABC News' Sasha Pezenik and Sony Salzman contributed to this report.。

Current article:http://www.feizengbubaipeirangnalouchuo.sbs/xqcmry/w8son.html

Published on:18:19:56